Avastin rejected for breast cancer use
00:40An FDA panel on Wednesday rejected the controversial drug Avastin as a treatment for end-stage breast cancer. NBC's Brian Williams reports.
An FDA panel on Wednesday rejected the controversial drug Avastin as a treatment for end-stage breast cancer. NBC's Brian Williams reports.
